Photomicrography of nodular glomerulosclerosis in Kimmelstein-Wilson syndrome. Source: CDC
Find information on thousands of medical conditions and prescription drugs.

Diabetic nephropathy

Diabetic nephropathy (nephropatia diabetica), also known as Kimmelstiel-Wilson syndrome and intercapillary glomerulonephritis, is a progressive kidney disease caused by angiopathy of capillaries in the kidney glomeruli. It is characterized by nodular glomerulosclerosis. It is due to longstanding diabetes mellitus, and is a prime cause for dialysis in many Western countries. more...

Home
Diseases
A
B
C
D
Dandy-Walker syndrome
Darier's disease
Dementophobia
Demyelinating disease
Dendrophobia
Dengue fever
Dental fluorosis
Dentinogenesis imperfecta
Dentophobia
Depersonalization disorder
Dermatitis herpetiformis
Dermatofibroma
Dermatographic urticaria
Dermatomyositis
Dermatophytosis
Desmoplastic small round...
Dextrocardia
Diabetes insipidus
Diabetes mellitus
Diabetes, insulin dependent
Diabetic angiopathy
Diabetic nephropathy
Diabetic neuropathy
Diamond Blackfan disease
Diastrophic dysplasia
Dibasic aminoaciduria 2
Diethylstilbestrol...
DiGeorge syndrome
Dilated cardiomyopathy
Diphallia
Diphtheria
Dipsophobia
Dissociative amnesia
Dissociative fugue
Dissociative identity...
Distemper
Diverticulitis
Diverticulosis
Dk phocomelia syndrome
Doraphobia
Double outlet right...
Downs Syndrome
Dracunculiasis
Duane syndrome
Dubin-Johnson syndrome
Dubowitz syndrome
Duchenne muscular dystrophy
Dupuytren's contracture
Dwarfism
Dysbarism
Dysgerminoma
Dyskeratosis congenita
Dyskinesia
Dysmorphophobia
Dysplasia
Dysplastic nevus syndrome
Dysthymia
Dystonia
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

History

The syndromed was discovered by British physician Clifford Wilson (1906-1997) and Germany-born American physician Paul Kimmelstiel (1900-1970) and was published for the first time in 1936.

Epidemiology

The syndrome can be seen in patients with chronic diabetes (15 years or more after onset), so patients are usually of older age (between 50 and 70 years old). The disease is progressive and may cause death two or three years after the initial lesions. and is more frequent in women. Diabetic nephropathy is the most common cause of chronic kidney failure and end-stage kidney disease in the United States. People with both type 1 and type 2 diabetes are at risk. The risk is higher if blood-glucose levels are poorly controlled. However, once nephropathy develops, the greatest rate of progression is seen in patients with poor control of their blood pressure.

Etiopathology

The earliest detectable change in the course of diabetic nephropathy is a thickening in the glomerulus. At this stage, the kidney may start allowing more albumin (plasma protein) than normal in the urine (albuminuria), and this can be detected by sensitive medical tests for albumin. This stage is called "microabuminuria". It can appear 5 to 10 years before other symptoms develop. As diabetic nephropathy progresses, increasing numbers of glomeruli are destroyed by nodular glomerulosclerosis. Now the amounts of albumin being excreted in the urine increases, and may be detected by ordinary urinalysis techniques. At this stage, a kidney biopsy clearly shows diabetic nephropathy.

Signs and symptoms

Kidney failure provoked by glomerulosclerosis lead to fluid filtration deficits and other disorders of kidney function. There is an increase in blood pressure (hypertension) and of fluid retention in the body (edema). Other complications may be arteriosclerosis of the renal artery and proteinuria (nephrotic syndrome).

Throughout its early course, diabetic nephropathy has no symptoms. They develop in late stages and may be a result of excretion of high amounts of protein in the urine or due to renal failure:

  • edema: swelling, usually around the eyes in the mornings; later, general body swelling may result, such as swelling of the legs
  • foamy appearance or excessive frothing of the urine
  • unintentional weight gain (from fluid accumulation)
  • anorexia (poor appetite)
  • nausea and vomiting
  • malaise (general ill feeling)
  • fatigue
  • headache
  • frequent hiccups
  • generalized itching

The first laboratory abnormality is a positive microalbuminuria test. Most often, the diagnosis is suspected when a routine urinalysis of a person with diabetes shows too much protein in the urine (proteinuria). The urinalysis may also show glucose in the urine, especially if blood glucose is poorly controlled. Serum creatinine and BUN may increase as kidney damage progresses.

Read more at Wikipedia.org


[List your site here Free!]


Diet may slow progression of diabetic nephropathy - Patient Oriented Evidence That Matters
From Journal of Family Practice, 9/1/03 by Anne Mounsey

Facchini FS, Saylor KL. A low-iron-available, polyphenol-enriched, carbohydrate-restricted diet to slow progression of diabetic nephropathy. Diabetes 2003; 52:1204-1209.

* PRACTICE RECOMMENDATIONS

A polyphenol-enriched diet with 50% carbohydrate restriction and low iron availability was superior to a conventional protein-restricted diet in slowing the progression of diabetic nephropathy.

These findings must be confirmed by additional high-quality studies before physicians can routinely recommend a change from the conventional low-protein diet. Current use of this diet is limited, as many nutritionists--even those specializing in diabetes--have no knowledge of it.

* BACKGROUND

Patients with end-stage renal disease are usually encouraged to follow a low-protein diet to slow the progression of their renal disease. This study was conducted to determine whether a carbohydrate-restricted, low-iron/polyphenol-enriched (CR-LIPE) diet was more effective than a conventional protein-restricted diet at slowing the progression of diabetic nephropathy. Foods rich in polyphenols include olive off, green tea, cranberries, grapes, and red wine.

* POPULATION STUDIED

A total of 191 patients with type 2 diabetes--men and women aged 49 to 62 years who were referred to nephrology clinics in California for impending renal failure--were recruited. Subjects had a history of diabetes for 5 to 15 years, with glycosylated hemoglobin (Hb[A.sub.1C]) of 6.0% to 9.3%. Current medications for both hypertension management and glucose control were continued. When there was doubt as to the cause of renal failure, a renal biopsy was performed to confirm the diagnosis of diabetic nephropathy. The ethnicity of the subjects is not mentioned. Results are likely generalizable to a diabetic population with advanced renal disease seen in a nephrology clinic.

* STUDY DESIGN AND VALIDITY

This was a nonblinded, randomized controlled trial, although the method of randomization is not specified. Subjects were assigned with concealed allocation to either the CR-LIPE diet or the control diet, a conventional protein-restricted diet (0.8 g/kg). The main features of the CR-LIPE diet were 50% carbohydrate reduction; iron-enriched meats are replaced with iron-poor meats and foods known to inhibit iron absorption; elimination of all beverages apart from tea, water, and red wine; and the use of olive off for frying and dressings. No attempt was made to assess compliance to either diet.

Analysis was by intention-to-treat; it is unknown whether the outcome assessors were blinded to group assignment. Patients were followed for a mean of 3.9 years (range, 0.7-5.3 years); 21 (11%) were lost to follow-up (9 in the CR-LIPE group, 12 in the control group). Weaknesses included small sample size, unclear method of randomization, lack of information on compliance with the diets, and uncertainty as to whether outcomes were assessed blindly.

* OUTCOMES MEASURED

Disease-oriented outcomes included doubling of serum creatinine and end-stage renal disease as defined by serum creatinine >6.0 mg/dL. Patient-oriented outcomes included the need for renal replacement therapy or transplantation and all-cause mortality.

* RESULTS

No significant difference was seen in the baseline characteristics of the 2 groups. Serum creatinine doubled in 19 (21%) of patients on the CR-LIPE diet vs 31 (39%) control subjects (P<.01). Renal replacement therapy or death occurred in 18 (20%) of patients on the CR-LIPE diet and in 31 (39%) control subjects (P<.01; number needed to treat=5).

These findings were independent of initial serum creatinine, 24-hour protein, blood pressure, Hb[A.sub.1C], and the use of angiotensin-converting enzyme inhibitors.

Anne Mounsey, MD, Department of Family Medicine, University of Virginia, Charlottesville. E-mail: alm2d@virginia.edu.

COPYRIGHT 2003 Dowden Health Media, Inc.
COPYRIGHT 2003 Gale Group

Return to Diabetic nephropathy
Home Contact Resources Exchange Links ebay